Institutional investors purchased a net $53.0 thousand shares of VICL during the quarter ended June 2017. This may signal that the smart money is gaining interest in this company as the 24.20% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BRIDGEWAY CAPITAL MANAGEMENT, IN... Bought 87.5 Thousand shares of Vical Inc
RENAISSANCE TECHNOLOGIES LLC Bought 62.3 Thousand shares of Vical Inc
NEW YORK STATE COMMON RETIREMENT... Bought 59.5 Thousand shares of Vical Inc